nasdaq:imgn
|
31070
|
Apr 21st, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
379.00
|
Open
|
|
Apr 20th, 2024 11:36PM
|
Apr 20th, 2024 11:36PM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:imgn
|
31070
|
Apr 20th, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
379.00
|
Open
|
|
Apr 19th, 2024 11:34PM
|
Apr 20th, 2024 05:09PM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:imgn
|
31070
|
Apr 19th, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
381.00
|
Open
|
|
Apr 18th, 2024 11:41PM
|
Apr 18th, 2024 11:41PM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:imgn
|
31070
|
Apr 18th, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
383.00
|
Open
|
|
Apr 17th, 2024 11:49PM
|
Apr 18th, 2024 06:29PM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:imgn
|
31070
|
Apr 17th, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
384.00
|
Open
|
|
Apr 16th, 2024 11:31PM
|
Apr 17th, 2024 02:54PM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:imgn
|
31070
|
Apr 16th, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
384.00
|
Open
|
|
Apr 15th, 2024 11:27PM
|
Apr 16th, 2024 11:10AM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:imgn
|
31070
|
Apr 15th, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
383.00
|
Open
|
|
Apr 14th, 2024 11:23PM
|
Apr 15th, 2024 04:52PM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:imgn
|
31070
|
Apr 14th, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
384.00
|
Open
|
|
Apr 13th, 2024 11:12PM
|
Apr 13th, 2024 11:12PM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:imgn
|
31070
|
Apr 13th, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
384.00
|
Open
|
|
Apr 12th, 2024 11:03PM
|
Apr 13th, 2024 11:37AM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:imgn
|
31070
|
Apr 12th, 2024 12:00AM
|
ImmunoGen, Inc.
|
28K
|
385.00
|
Open
|
|
Apr 11th, 2024 11:08PM
|
Apr 12th, 2024 08:32AM
|
ImmunoGen is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
|
Open
|
1 N Waukegan Rd
|
North Chicago
|
Illinois
|
US
|
60064
|
|
ImmunoGen
|
Health Care
|
Pharmaceuticals & Biotechnology
|